Alcohol-associated liver disease (ALD) is caused by alcohol metabolism's effects on the liver. The underlying mechanisms from a metabolic view in the development of alcohol-associated liver cirrhosis (ALC) are still elusive. We performed an untargeted serum metabolomic analysis in 14 controls, 16 patients with ALD without cirrhosis (NC), 27 patients with compensated cirrhosis, and 79 patients with decompensated ALC. We identified two metabolic fingerprints associated with ALC development (38 metabolites) and those associated with hepatic decompensation (64 metabolites) in ALC. The cirrhosis-associated fingerprint (eigenmetabolite) showed a better capability to differentiate ALC from NC than the aspartate aminotransferase-to-platelet ratio index score. The eigenmetabolite associated with hepatic decompensation showed an increasing trend during the disease progression and was positively correlated with the Model for End-Stage Liver Disease score. These metabolic fingerprints belong to the metabolites in lipid metabolism, amino acid pathway, and intermediary metabolites in the tricarboxylic acid cycle. Conclusion: The metabolomic fingerprints suggest the disturbance of the metabolites associated with cellular energy supply as an underlying mechanism in the development and progression of alcoholic cirrhosis. (Hepatology Communications 2021;0:1-15). T he prevalence of alcohol-associated liver disease (ALD) is on the rise, and ALD has become one of the common noninfectious liver diseases worldwide. (1-3) ALD represents a spectrum of histopathological changes ranging from alcoholic steatosis, steatohepatitis, advanced fibrosis, and cirrhosis. Alcoholic steatosis, a reversible process following abstinence, occurs in most if not all heavy drinkers. However, only 20% of these patients develop alcoholic hepatitis and cirrhosis. (4) Alcohol-associated liver cirrhosis (ALC) is the leading cause of mortality in patients with ALD. (4,5) It accounts for 1% of all deaths worldwide and 50% of cirrhosis-related deaths. (6) The prognosis is poor with 5-year mortality around 85%, especially in those with complications from portal hypertension, such as variceal bleeding, hepatic encephalopathy, and ascites. (7) Once ingested, alcohol is primarily metabolized by the liver with by-products such as acetaldehyde and reactive oxygen species (ROS), leading to liver